Correlation between clinical characteristics and proliferative activity in patients with craniopharyngioma

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 6, 2004, Pages 889-892

  Losa, M ^a,b   Vimercati, A ^b   Acerno, S ^b   Barzaghi, R L ^b   Mortini, P ^b   Mangili, F ^a   Terreni, M R ^a   Santambrogio, G ^a   Giovanelli, M ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; CYCLIN A; KI 67 ANTIGEN; PARAFFIN;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CRANIOPHARYNGIOMA; DIABETES INSIPIDUS; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; STATISTICAL SIGNIFICANCE; TUMOR GROWTH;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; BRAIN NEOPLASMS; CELL CYCLE; CHILD; CRANIOPHARYNGIOMA; CYCLIN A; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 2442683002     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2003.012781     Document Type: Article

References (27)

1. Zülch K. Brain tumors. Their biology and pathology. New York: Springer-Verlag, 1986.
2. Bunin GR, Surawicz TS, Witman PA, et al. The descriptive epidemiology of craniopharyngioma. J Neurosurg 1998;89:547-51.
3. Szeifert GT, Sipos L, Horváth M, et al. Pathological characteristics of surgically removed craniopharyngiomas: analysis of 131 cases. Acta Neurochir (Wien) 1993;124:139-43.
4. Losa M, Franzin A, Mortini P, et al. Usefulness of markers of cell proliferation in the management of pituitary adenomas. Clin Sci 1998;95:129-35.
5. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000;182:311 -22.
6. MacCallum DE, Hall PA. The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle. J Pathol 2000;190:537-44.
7. Hall PA, Woods AL. Immunohistochemical markers of cellular proliferation: achievements, problems and prospects. Cell Tissue Kinet 1990;23:505-22.
8. Prosperi E, Stivala LA, Scovassi AI, et al. Cyclins: relevance of subcellular localization in cell cycle control. Eur J Histochem 1997;41:161-8.
9. Desdouets C, Sobezack-Thépot J, Murphy M, et al. Cyclin A: function and expression during cell proliferation. Prog Cell Cycle Res 1995;1:115-23.
10. Nishi T, Kuratsu JI, Takeshima H, et al. Prognostic significance of the MIB-1 labeling index for patient with craniopharyngioma. Int J Mol Med 1999;3:157-61.
11. Ravaghan R, Dickey WT Jr, Margraf LR, et al. Proliferate activity in craniapharyngiomas: clinicopathological correlations in adults and children. Surg Neurol 2000;54:241-8.
12. Kim S-K, Wang K-C, Shin S-H, et al. Radical excision of pediatric craniopharyngioma: recurrence pattern and prognostic factors. Childs Nerv Syst 2001;17:531-6.
13. Losa M, Franzin A, Mangili F, et al. Proliferation index of nonfunctioning pituitary adenomas: Correlations with clinical characteristics and long-term follow-up results. Neurosurgery 2000;47:1313-19.
14. Losa M, Barzaghi R, Mortini P, et al. Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors: comparison between micro- and macroadenomas. Am J Patnol 2000;156:245-51.
15. Losa M, Ciccarelli E, Mortini P, et al. Effects of octreotide treatment on the proliferation and apoptotic index of GH-secreting pituitary adenomas. J Clin Endocrinol Metab 2001;86:5194-200.
16. Duff JM, Meyer FB, Ilstrup DM, et al. Long-term outcomes for surgically resected craniopharyngiomas. Neurosurgery 2000,46:291-305.
17. Adamson TE, Wiestler OD, Kleihues P, et al. Correlation of clinical and pathological features in surgically treated craniopharyngiomas. J Neurosurg 1990,73:12-17.
18. Carmel PW, Antunes JL, Chang CH. Craniopharyngiomas in children. Neurosurgery 1982;11:382-9.
19. Stahnke N, Grubel G, Lagenstein I, et al. Long-term follow-up of children with craniopharyngioma. Eur J Pediatr 1984;142:179-85.
20. Fischer EG, Welch K, Shillito J Jr, et al. Craniopharyngiomas in children. Long-term effects of conservative surgical procedures combined with radiation therapy. J Neurosurg 1990;73:534-40.
21. Yasargil MG, Curcic M, Kis M, et al. Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J Neurosurg 1990;73:3-11.
22. Weiner HL, Wisoff JH, Rosenberg ME, et al. Craniopahryngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery 1994;35:1001-11.
23. Crotty TB, Scheithauer BW, Young WF, et al. Papillary craniopharyngioma: a clinicopathological study of 48 cases. J Neurosurg 1995;83:206-14.
24. Eldevik OP, Blaivas M, Gabrielsen TO, et al. Craniopharyngioma: radiologic and histologic findings and recurrence. Am J Neuroradiol 1996;17:1427-39.
25. Villani RM, Tomei G, Bello L, et al. Long-term results of treatment for craniopharyngioma in children. Childs Nerv Syst 1997;13:397-405.
26. Fahlbusch R, Honegger J, Paulus W, et al. Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 1999;90:237-50.
27. Slootweg PJ. p53 protein and Ki-67 reactivity in epithelial odontogenic lesions. An immunohistochemical study. J Oral Pathol Med 1995;24:393-7.